Maveropepimut-S, an immune-educating therapy with durable clinical benefit in patients with recurrent ovarian cancer

GYNECOLOGIC ONCOLOGY(2023)

Cited 0|Views8
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined